-Synergetics USA Inc. has  received 510(k) marketing clearance from the FDA for its proprietary vitrectomy  system (VersaVIT).

“The entry  of [of our vitrectomy system] into the global vitrectomy market is a major  milestone in Synergetics’ strategy to enter into higher growth areas of retinal  surgery,” said David M. Hable, Synergetics’ president and chief executive  officer. “We believe that [this system] is a ‘game changer’ given its  functionality, portability, and competitive pricing relative to traditional  vitrectomy systems.”

The  vitrectomy system is under review for CE mark approval.

Synergetics USA Inc. has received 510(k) marketing clearance from the FDA for its proprietary vitrectomy system (VersaVIT).